0001104659-18-015618.txt : 20180307 0001104659-18-015618.hdr.sgml : 20180307 20180307181826 ACCESSION NUMBER: 0001104659-18-015618 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180307 FILED AS OF DATE: 20180307 DATE AS OF CHANGE: 20180307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Laumas Sandeep CENTRAL INDEX KEY: 0001721664 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38410 FILM NUMBER: 18674478 MAIL ADDRESS: STREET 1: 8480 HONEYCUTT RD, SUITE 200 CITY: RALEIGH STATE: NC ZIP: 27615 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BioXcel Therapeutics, Inc. CENTRAL INDEX KEY: 0001720893 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 821386754 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 780 EAST MAIN STREET CITY: BRANFORD STATE: CT ZIP: 06405 BUSINESS PHONE: 203-643-8060 MAIL ADDRESS: STREET 1: 780 EAST MAIN STREET CITY: BRANFORD STATE: CT ZIP: 06405 3 1 a3.xml 3 X0206 3 2018-03-07 0 0001720893 BioXcel Therapeutics, Inc. BTAI 0001721664 Laumas Sandeep C/O BIOXCEL THERAPEUTICS, INC. 780 EAST MAIN STREET BRANFORD CT 06405 1 0 0 0 Stock Options 0.41 2027-08-23 Common Stock 86979 D The shares underlying this stock option vest as follows: 29,151 shares shall vest on August 22, 2018, and 28,914 shares shall vest on each of August 22, 2019 and August 22, 2020. /s/ Sandeep Laumas 2018-03-07